Jim Simons
LUNG icon

Jim Simons’s Pulmonx LUNG Stock Holding History

Jim Simons’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$413K Buy
320,300
+28,300
+10% +$46.8K ﹤0.01% 2678
2025
Q4 		$645K Sell
292,000
-40,810
-12% -$76.7K ﹤0.01% 2476
2025
Q3 		$539K Buy
332,810
+81,500
+32% +$170K ﹤0.01% 2757
2025
Q2 		$651K Buy
251,310
+86,010
+52% +$339K ﹤0.01% 2707
2025
Q1 		$1.11M Sell
165,300
-55,210
-25% -$391K ﹤0.01% 2353
2024
Q4 		$1.5M Buy
220,510
+61,500
+39% +$405K ﹤0.01% 2236
2024
Q3 		$1.32M Sell
159,010
-142,400
-47% -$1.03M ﹤0.01% 2284
2024
Q2 		$1.91M Buy
301,410
+34,800
+13% +$268K ﹤0.01% 1912
2024
Q1 		$2.47M Buy
266,610
+71,447
+37% +$838K ﹤0.01% 1892
2023
Q4 		$2.49M Buy
195,163
+117,153
+150% +$1.22M ﹤0.01% 1816
2023
Q3 		$806K Sell
78,010
-14,390
-16% -$167K ﹤0.01% 2445
2023
Q2 		$1.21M Sell
92,400
-102,445
-53% -$1.25M ﹤0.01% 2347
2023
Q1 		$2.18M Buy
194,845
+176,803
+980% +$1.75M ﹤0.01% 1978
2022
Q4 		$152K Buy
+18,042
New +$172K ﹤0.01% 3505
2022
Q2 		– Sell
-81,600
Closed -$2.02M – 4435
2022
Q1 		$2.02M Sell
81,600
-71,700
-47% -$1.85M ﹤0.01% 2228
2021
Q4 		$4.92M Buy
153,300
+63,200
+70% +$2.31M 0.01% 1545
2021
Q3 		$3.24M Buy
90,100
+61,800
+218% +$2.43M ﹤0.01% 1725
2021
Q2 		$1.25M Buy
+28,300
New +$1.23M ﹤0.01% 2560

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jim Simons's LUNG Position: Q1 2026 in Review

Jim Simons increased its Pulmonx (LUNG) stake by 9.7% in Q1 2026, buying an estimated $46.8K and bringing the position to 320,300 shares worth $413K. The position accounts for ﹤0.01% of the portfolio, ranked #2678.

Jim Simons first reported a position in LUNG in Q2 2021 and has held it in 18 quarters since. The position peaked at $4.92M in Q4 2021. 114 funds tracked by Wall St. Rank hold LUNG as of Q1 2026.

  • Jim Simons held 320,300 shares of Pulmonx worth $413K as of Q1 2026.
  • Jim Simons bought 28,300 Pulmonx shares in Q1 2026, an estimated $46.8K.
  • Pulmonx made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #2678 holding.
  • Jim Simons first reported a position in Pulmonx in Q2 2021 and has held it in 18 quarters since.
  • Jim Simons's Pulmonx position peaked at $4.92M in Q4 2021.
  • 114 funds tracked by Wall St. Rank held Pulmonx as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.